ËÜÆü¤Ï¡¢¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó ¤Ë¤Ä¤¤¤Æ¤Î¤ªÏä·¡£

¤¶¤Ã¤¯¤ê¸À¤¦¤È

¡¦¿®Íê¤Ç¤­¤ë¥¨¥Ó¥Ç¥ó¥¹¤«¤é¸«¤Æ¡¢¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤Ï¡¢

Ǿ¤Î¥Ñ¥Õ¥©¡¼¥Þ¥ó¥¹¤ò°ÂÁ´¤Ë¹â¤á¤ë²ÄǽÀ­¤¬¹â¤¤¡£

¤Ç¤Ï¡¢¤½¤Î¥¨¥Ó¥Ç¥ó¥¹¤È¤Ï¡©

¡¦¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤Ï¡¢µ­²±ÎϤΥѥե©¡¼¥Þ¥ó¥¹¤ò½õ¤±¤ë¡£

¼õ¸³À¸¤Ï¡¢¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤È¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹¤ÎÁȤ߹ç¤ï¤»¤òÁª¤Ö¤Ù¤­¤Ç¤·¤ç¤¦¡£

¤Ç¤Ï¡¢¤½¤ÎʬÎ̤Ȥϡ©

¡¦¤½¤ì¤é¤Î¾åµ­¾ò·ï¤òËþ¤¿¤¹¥µ¥×¥ê¤Î¤Ò¤È¤Ä¤Ï¡¢¥­¥í¥ó¤«¤éȯÇ䤵¤ì¤Æ¤¤¤ëSWITCH¡¢¤Þ¤¿¤ÏƱ¤¸¤¯¥­¥í¥ó¤«¤éȯÇ䤵¤ì¤Æ¤¤¤ëCOOL SWITCH¡£





¤½¤ì¤Ç¤ÏÀâÌÀ¤·¤Æ¤Þ¤¤¤ê¤Þ¤¹¡£

¤Þ¤º¤Ï¡¢¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤È¤Ï¤Ê¤ó¤Ç¤¢¤ë¤«¡©


¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤Ï¡¢ºÙ˦Ëì¤ò¹½À®¤¹¤ë¥ê¥ó»é¼Á¤Î¤Ò¤È¤Ä¡£


¿Í´Ö¤ÎºÙ˦¤Ï¡¢¤¹¤Ù¤Æ¤³¤Î»é¼Á¤ò´Þ¤ó¤Ç¤ª¤ê¡¢À¸Â¸¤ËɬÍפʵ¡Ç½¤Ï¡¢¤³¤Î¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤ËÍê¤Ã¤Æ¤¤¤ë¡¢¤È¸À¤¦¤³¤È¤¬¤Ç¤­¤Þ¤¹¡£


¤¿¤È¤¨¤Ð¡¢

¡¦À¸Ì¿³èÆ°¤Î¥¨¥Í¥ë¥®¡¼¤Î»ºÀ¸ (ATP»ºÀ¸)


¡¦À¸Ì¿µ¡Ç½¤òÊݤĤ¿¤á¤Î¥¤¥ª¥ó¤Î¥Û¥á¥ª¥¹¥¿¥·¥¹µ¡Ç½


¡¦ºÙ˦¥ì¥Ù¥ë¤Ç¤Î³èÀ­²½¤äÉÔ³èÀ­²½¡¢¤Ê¤É¤Ê¤É¡£


¤½¤·¤Æ¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤Ï¡¢¤È¤¯¤Ë¡¢¥Ë¥å¡¼¥í¥ó¤ä¥·¥Ê¥×¥¹¤ÎËì¤Ë¿¤¯Â¸ºß¤·[1]¡¢


¥¢¥»¥Á¥ë¥³¥ê¥ó¤ä¥É¡¼¥Ñ¥ß¥ó¡¢¥Î¥ë¥¢¥É¥ì¥Ê¥ê¥ó¤È¤¤¤Ã¤¿¿À·ÐÅÁãʪ¼Á¤ÎÊü½Ð¤ä¥·¥°¥Ê¥ëÅÁã¤Ë´ØÍ¿¤·¤Æ¤¤¤Þ¤¹¡£[2,3,4,5]¡¡


¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤Î¡¢Æ¬Ç¾¤Ø¤ÎÍ­±×À­¤Ë¤Ä¤¤¤Æ¡¢²Ê³ØŪ¸¦µæ¤Ï¼¡¤Î¸ú²Ì¤òÊó¹ð¤·¤Æ¤¤¤Þ¤¹¡£


¡¦µ­²±ÎϤβþÁ±ºîÍÑ


¡¦¿À·ÐÊݸîºîÍÑ


¡¦¹³¥¹¥È¥ì¥¹ºîÍÑ


¡¦¹³¤¦¤ÄºîÍÑ


Ǿ¤Î·ò¹¯¤¬µ¤¤Ë¤Ê¤ëÊý¤Ë¡¢¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤Ï¡¢¤¹¤Ç¤ËÄêÈ֤Υµ¥×¥ê¡¢¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£



¤Ç¤Ï¡¢¤³¤ó¤Ê¸¦µæÊó¹ð¤Ï¤¤¤«¤¬¤Ç¤·¤ç¤¦¡£


Ê¿¶ÑǯÎð20.4ºÐ¤Î·ò¾ï¿Í¤òÂоݤˤ·¤¿¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹¤È¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤È¤ÎÁȤ߹ç¤ï¤»¤òÄ´ºº¤·¤¿¤â¤Î¤Ç¤¹¡£

https://www.ncbi.nlm.nih.gov/pubmed/17457961

ÁȤ߹ç¤ï¤»¤Ï¤³¤¦¡£


1) ¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹120­Ó ¤òñÂΤÇÀݼ褷¤¿¾ì¹ç¡£


2) ¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹120­Ó ¤È¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó (PS) 360­Ó ¤òƱ»þ¤ËÀݼ褷¤¿¾ì¹ç¡£


3) ¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹120­Ó ¤È¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥³¥ê¥ó (PC) 360­Ó ¤òƱ»þ¤ËÀݼ褷¤¿¾ì¹ç¡£


¤½¤Î»°¥Ñ¥¿¡¼¥ó¤Ç¡¢°ìÄê»þ´Ö¸å¤Ë


¡ÖÃí°ÕÎϤΥ¹¥Ô¡¼¥É¡×


¡ÖÃí°ÕÎϤÎÀµ³ÎÀ­¡×


¡Öµ­²±ÎϤΥ¹¥Ô¡¼¥É¡×


¡Öµ­²±¤ÎÀµ³ÎÀ­¡×


¡ÖÆ󼡵­²±¡×


¡Ö¥ï¡¼¥­¥ó¥°¥á¥â¥ê¡¼¡× ¤òÄ´¤Ù¤Æ¤¤¤Þ¤¹¡£


·ë²Ì


£²) ¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹¤È¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó ¤ÎÁȤ߹ç¤ï¤»¤¬¡¢ºÇ¤â¸ú²Ì¤Î¹â¤¤ÁȤ߹ç¤ï¤»¡¢¤À¤Ã¤¿¤è¤¦¤Ç¤¹¡£


¡ü ¡ÖÃí°ÕÎϤΥ¹¥Ô¡¼¥É¡× ¤Ë¤ª¤¤¤Æ¤Ï

¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹Ã±ÆȤÎ1) ¤È

¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹¤ÈPC¤Î3) ¤¬¡¢

2.5»þ´Ö¸å¤Þ¤ÇÍ­°Õ¤Ë®¤¯¤Ê¤Ã¤¿¡£


¤½¤·¤Æ¡¢¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹¤ÈPS¤ÎƱ»þÀݼè 2) ¤Ï¡¢

¤µ¤é¤Ë¡¢6»þ´Ö¸å¤Ë¤ª¤¤¤Æ¤âÍ­°Õ¤Ë®¤¤¡£

¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹¤È¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¡ÊPS¡Ë¤Ï¡¢Ãí°ÕÎϤΥ¹¥Ô¡¼¥É¤Ë¤ª¤¤¤Æ¡¢ÁêÀ­¤¬Îɤ¤¤è¤¦¤Ç¤¹¡£


¡ü ¡ÖÃí°ÕÎϤÎÀµ³ÎÀ­¡× ¤Ç¤Ï


¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹¤ÈPS 2) ¤ÎÁȤ߹ç¤ï¤»¤ËÍ­°Õ¤Ê²þÁ±¤¬¤ß¤é¤ì¤¿¡£

¤³¤ì¤â¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹¤È¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¡ÊPS¡Ë¤¬Îɤ¤¤è¤¦¤Ç¤¹¡£


¡ü ¡Öµ­²±¤Î¥¹¥Ô¡¼¥É¡× ¤Ç¤Ï


¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹¤ÈPC 3) ¤¬4»þ´Ö¸å¤ËµÕ¤ËÃÙ¤¯¤Ê¤Ã¤¿¤¬¡¢

¤·¤«¤·¡¢¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹¤ÈPS 2) ¤Ï¡¢

Àݼ裱»þ´Ö¤«¤é£¶»þ´Ö¸å¤Î¤¹¤Ù¤Æ¤ÇÍ­°Õ¤Ë²þÁ±¤·¤¿¡£[6]


º£²ó¤Î¥¿¥¤¥È¥ë¤Ï¡¢¼¡¤Î¤è¤¦¤Ë½ñ¤­´¹¤¨¤ë¤Ù¤­¤«¤â¤·¤ì¤Þ¤»¤ó¡£


¡ÖǾ¤Î¥Ñ¥Õ¥©¡¼¥Þ¥ó¥¹¤Î¤¿¤á¤Ë¤Ï¡¢¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤È¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹¡¢¤³¤ÎÆó¤Ä¤òÊ»¤»¤ÆÀݤë¤Ù¤­¤Ç¤¢¤ë¡×


¤Ç¤Ï¤Ê¤¼¡¢¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤Ïµ­²±ÎϤò²þÁ±¤µ¤»¤ë¤Î¤Ç¤·¤ç¤¦¤«¡©

¤È¤¤¤¦Â³¤­¤Ï¡¢¥Ñ¡¼¥È£²¤Ç¡ª




¾åµ­¡¢¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹¤È¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤òÁȤ߹ç¤ï¤»¤Æ¤¤¤ë¥µ¥×¥ê¥á¥ó¥È¤Ï¡¢

¥­¥í¥ó¤«¤éȯÇ䤵¤ì¤Æ¤¤¤ë¥¹¥¦¥£¥Ã¥Á¤¬ÃΤé¤ì¤Æ¤¤¤Þ¤¹¡£

¥¹¥¦¥£¥Ã¥Á £²¥«¥×¥»¥ë¤Ë¤Ï¡¢
¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹120mg¡¢
ÂçƦ¥ì¥·¥Á¥óÃê½Ðʪ¡Ê¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó´ÞÍ­¡Ë100mg¡¢
¹âÎï¿Í»²¥¨¥­¥¹200mg¡¢
¥Ð¥³¥Ñ¥â¥Ë¥¨¥é¥¨¥­¥¹80mg ¤¬Æþ¤Ã¤Æ¤¤¤Þ¤¹¡£


¹âÎï¿Í»²¥¨¥­¥¹¤È¤¤¤¨¤Ð¡¢ÃËÀ­¤Î³èÎϤÇÃΤé¤ì¤Æ¤â¤¤¤Þ¤¹¤¬¡¢

¼Â¤Ï¡¢ÂçÊÑÍ¥¤ì¤¿¥¹¥Þ¡¼¥È¥Ï¡¼¥Ö¤Ç¤â¤¢¤ê¡¢Ç§Ãε¡Ç½¤ËÍ­ÍѤǤ¹¡£

¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹120mg¤È¹âÎï¿Í»²¥¨¥­¥¹200mg¤ÎÁȤ߹ç¤ï¤»¤Ï¡¢

µ­²±ÎϤäÃí°ÕÎϤËÍ­±×¡£

PMID: 30729756
https://www.ncbi.nlm.nih.gov/pubmed/?term=30729756




¤µ¤é¤Ë¡¢¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹ ¤È¥¢¥á¥ê¥«¿Í»²¥¨¥­¥¹¤ÎÁȤ߹ç¤ï¤»¤Ï¡¢

Ãí°ÕÎϤؤΥµ¥Ý¡¼¥ÈÎϤ¬¡¢¹âÎï¿Í»²¤è¤ê¤â¹â¤¤¤è¤¦¤Ç¤¹¡£

PMID:11394191
https://www.ncbi.nlm.nih.gov/pubmed/?term=11394191



¤Ê¤¼¤Ê¤é¡¢¥¢¥á¥ê¥«¿Í»²¥¨¥­¥¹¤Ë¤Ï¡¢¥ï¡¼¥­¥ó¥°¥á¥â¥ê¡¼¤Ø¤Î¥µ¥Ý¡¼¥È¤¬¼¨º¶¤µ¤ì¤Æ¤¤¤ë¤«¤é¤Ç¤¹¡£

PMID:2952762
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952762/





Ãí°ÕÎϤ˽ÅÅÀ¤ò¤ª¤¤¤Æ¥µ¥Ý¡¼¥È¤·¤¿¤¤Êý¤Ï¡¢

¥¢¥á¥ê¥«¿Í»²¥¨¥­¥¹¤¬Æþ¤Ã¤¿¥­¥í¥ó¤Î COOL SWTCH ¤¬Îɤ¤¤«¤â¤·¤ì¤Þ¤»¤ó¡£

Äɵ­¡§2019ǯ9·î¤Ë¡¢¾å½Ò¤·¤¿¸¦µæ¤ÇÍѤ¤¤é¤ì¤¿¥¤¥Á¥ç¥¦ÍÕ¥¨¥­¥¹120mg¤È¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó360m¤¬Æþ¤Ã¤¿¥µ¥×¥ê¡¢¥­¥í¥ó¤Î¡ÖMEMO¡×¤âȯÇ䤵¤ì¤Æ¤¤¤Þ¤¹¡£

¥Ñ¡¼¥È£²¤Ø

¢§¥¢¥Þ¥¾¥ó COOL SWITCH
https://www.amazon.co.jp/dp/B07P9XSK2G/

¢§¥¢¥Þ¥¾¥ó SWITCH
https://www.amazon.co.jp/dp/B0095GON76

¢§¥¢¥Þ¥¾¥ó MEMO
https://www.amazon.co.jp/dp/B07VM5PF5N


¿·switch %282%29

¿·hyper_switch %282%29

cool_switch01ÀÚ¼èÇò ºÇÇò



[1] Kidd PM. 1999. A review of nutrients and botanical in the integrative management of cognitive dysfunction. Altern Med Rev 4:38-43
[2] Bruni A,Toffano G.1982. Lysophophatidylserine, a short-lived intermediate with plasma membrane regulatory properties. Pharmaco Res Commun 14(6):469-484
[3] Yoshimura T, Sone S. 1990 Role of phosphatidylserine in membrane actions of tumor necrosis factor and interfoerons alpha and gamma. Biochem Int 20(4):697-705
[4] Cohen SA,Mueller WE.1992. Age related alterations in the mouse forebrain:partial restoration by chronic phosphatidylserine treatment. Brain Res 584: 174-180
[5] Moynagh PN, Williams DC.1992. Stabilization of the peripheral-type benzodiazepine acceptor by specific phospholipids. Biochem Pharmacol 43(9): 1939-1945
[6] D.O.Kennedy, C.F Haskell, P.L Mauri, A.B Scholey.2007. Acute cognitive effects of standardized Ginkgo biliba extract conplexed with phosphatidylserine. Hum.Psychopharmacol Clin Exp 2007 ;22:199-210
[7] Pedata F et.al. 1985. Phosphatidylserine increases acetylcholine release from cortical slices in aged rats. Neurobiol Aging 6(4): 337-339
[8] Benowitz LI et.al. 2000. ¡ÈGAP-43:an intrinsic determinant of neuronal development and plasticity¡É. Trends Neurosci 20(2):84-91
[9] Gianotti C et.al. 1993. B-50/GAP-43 phosphorylation in hippocampal slices from aged rats: effects of phosphatidylserine administration. Neurobiol Aging 14(5): 401-406
[10] ¼ò°æ Àµ»Î, ²ÃÆ£ ¹ë¿Í. 2010. ÂçƦ¥Û¥¹¥Õ¥¡¥Á¥¸¥ë¥»¥ê¥ó¤ÎǾµ¡Ç½²þÁ±¸ú²Ì Anti-aging Science 2(2): 57-61
[11] Calderon C, Huang ZH, Gage DA, et.al. 1994. Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidylserine. J Exp Med 180: 945-958
[12] Venema RC, Sayegh HS, Arnal JF, et.al. 1995. Role of enzyme calmodulin-binding domain in membrane association and phospholipid inhibition of endothelial nitric oxide synthase. J Bio Chem 270: 14705-14711
[13] Monastra G,Gross AH, Bruni A et.al. 1993. Phosphatidylserine, a putative inhibitor of tumor necrosis factor, prevents autoimmune demyelinaction. Neurology 43: 153-163
[14] Angelucci L, Ramacci MT, Taglialatela G, et.al. 1988. Nerve growth factor binding in aged rat central nervous system: effect of acetyl-L-carnitine. J Neuroscience Res 20:491-496
[15] Nunzi MG, Milan F, Guidolin D, Toffano G. 1987. Dendritic spine loss in hippocampus of aged rats Effect of brain phosphatidylserine administration. Neurobiol Aging 8:501-510
[16] Cenacchi T, Bertoldin T, Farina C, et.al. 1993. Cognitive decline in the elderly: a double-blind,placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging(Milano) 5:123-133
[17] Monteleone P,Beinat L, Tanzillo C, et.al. 1990. Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans. Neuroendocrinology 52:243-248
[18] Monteleone P, Maj M, Beinat L, et.al. 1992. Blunting by chronic hosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharmacol 42:385-388
[19] Maggioni M, Picotti GB, Bondiolotti GP,et.al. Effects of hosphatidylserine therapy in geriatric patients with depressive disdoers. Acta psychiatr Scand 81:265-270
[20] Crook T,Petrie W, Wells C, Massari DC. 1992. Effects of phosphatidylserine in Alzheimer¡Çs disease. Psychopharmacol 42:385-388
[21] Amaducci L. 1988. Phosphatidylserine in the treatment of Alzheimer¡Çs disease: results of a multicenter study. Psychopharmacol Bull 24:130-134
[22] Parris M. 1999. A review of nutrients and botanicals in the integratetive management of cognitive dysfunction. Alternative Medicine Review 4(3):144-161